UNSPSC 51334310: Clopenthixol decanoate

This classification denotes a dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2HFX55AF4Y, chemically known as clopenthixol decanoate, (e/z)-, but more generally known as clopenthixol decanoate, which bears US NIH Compound Identifier 6450313. European Medicines Agency schedules Clopenthixol decanoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01364MIG. Most nations, for tariff and trade purposes, schedule clopenthixol decanoate under HS 29349990 and SITC 51579.

SMILES: As of Q4 2014, CLOPENTHIXOL DECANOATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51334310 Clopenthixol decanoate is a Commodity code that shows a significant mismatch between its nominal pharmaceutical scope and the actual state and local procurement activity recorded under it. The recent opportunity tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—does not involve clopenthixol decanoate, an antipsychotic medication used in psychiatric treatment. Instead, the county is procuring naloxone (an opioid overdose reversal agent) and safe drug deactivation systems for community health initiatives. This tagging appears to be an error in the source data rather than a reflection of genuine purchasing activity in the code's intended scope.

The single recent solicitation on file is Seminole County IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 (a historical date inconsistent with the posting date), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with an optional one-year renewal, fixed-fee pricing, and potential FEMA funding, with compliance requirements including drug-free workplace certification, E-Verify, workers' compensation, and commercial general liability insurance. No recent state and local opportunities properly aligned with clopenthixol decanoate procurement appear in the dataset; the code warrants further verification for relevance to your target markets.